ANGEL ONE: CO ADDS 85000 ACTIVE CLIENTS IN AUGUST: ENTRACKR
GROWW: CO ADDS 2.23 LAKHS ACTIVE CLIENTS IN AUGUST
GROWW: CO ADDS 2.23 LAKHS ACTIVE CLIENTS IN AUGUST
👍3
🚀 EXCLUSIVE INDEX OPTIONS INTRADAY CALLS
🎯 Coverage: NIFTY | BANK NIFTY | SENSEX
📌 Proper Entry, Stop Loss, Target, Timely Trade Updates
🔥 SPECIAL OFFER – 20% OFF
Regular Fee: ₹5,000/month | Launch Price: ₹4,000/month
📲 Join Now: wa.me/919625697175
Research-based calls only. Market investments are subject to market risks. No assured returns or profits are promised.
🎯 Coverage: NIFTY | BANK NIFTY | SENSEX
📌 Proper Entry, Stop Loss, Target, Timely Trade Updates
🔥 SPECIAL OFFER – 20% OFF
📲 Join Now: wa.me/919625697175
Research-based calls only. Market investments are subject to market risks. No assured returns or profits are promised.
❤5
Balaji Amines has officially transitioned from project phase to commercial production for its much-anticipated Dimethyl Ether (DME) facility. Located in Solapur, this 100,000 TPA plant marks a significant milestone as India's first domestic commercial-scale DME manufacturing unit, aligning with the national goal of reducing LPG import dependency.
The move is expected to attract institutional interest due to the ESG-friendly nature of DME as a cleaner fuel. For the specialty chemicals sector, this sets a benchmark for import substitution. Capital allocation towards downstream high-value products like DME suggests a shift toward margin protection over pure volume growth.
Dimethyl Ether (DME) is an environmentally friendly fuel that can be blended with LPG or used as a standalone fuel in diesel engines. The global shift toward decarbonization has made DME a key candidate for the clean energy transition in the industrial and transport sectors.
The move is expected to attract institutional interest due to the ESG-friendly nature of DME as a cleaner fuel. For the specialty chemicals sector, this sets a benchmark for import substitution. Capital allocation towards downstream high-value products like DME suggests a shift toward margin protection over pure volume growth.
Dimethyl Ether (DME) is an environmentally friendly fuel that can be blended with LPG or used as a standalone fuel in diesel engines. The global shift toward decarbonization has made DME a key candidate for the clean energy transition in the industrial and transport sectors.
❤5👍1
Welaxis Research | SEBI Registered RA
5 Stock derailed Technical Analysis with entry, SL & Target available for ₹999 It is free for paid subscribers (any plan) To buy paytm/gpay on 9871097175 and send payment screenshot with your name and email. Report will be sent via email.
this is shared in paid telegram channel for all members.
IOL Chemicals is the direct beneficiary of any Ibuprofen shortage in Europe - this has happened before.
Current status:
Europe is again seeing intermittent shortages. The Ireland HSE July 2026 shortage list shows Ibuprofen 200mg 100T (Accord) as "Awaiting return date", similar tightness was reported in UK/EU in 2023-24 due to supply chain issues. 0efa
Why IOL benefits:
- IOL is world's largest Ibuprofen API producer - 33% global market share, capacity ∼12,000 TPA (earlier 7,200 TPA)
- It has EU-GMP and CEP from EDQM for Ibuprofen, so it can directly export to Europe - unlike many Indian/Chinese players who need 2-3 years approval.
- History: In 2018 when BASF's Bishop, Texas plant shut due to technical fault, Ibuprofen prices spiked 15% domestic and 25% globally, IOL shares surged 25% in July alone, because Ibuprofen was 85-90% of its pharma sales.
Current status:
Europe is again seeing intermittent shortages. The Ireland HSE July 2026 shortage list shows Ibuprofen 200mg 100T (Accord) as "Awaiting return date", similar tightness was reported in UK/EU in 2023-24 due to supply chain issues. 0efa
Why IOL benefits:
- IOL is world's largest Ibuprofen API producer - 33% global market share, capacity ∼12,000 TPA (earlier 7,200 TPA)
- It has EU-GMP and CEP from EDQM for Ibuprofen, so it can directly export to Europe - unlike many Indian/Chinese players who need 2-3 years approval.
- History: In 2018 when BASF's Bishop, Texas plant shut due to technical fault, Ibuprofen prices spiked 15% domestic and 25% globally, IOL shares surged 25% in July alone, because Ibuprofen was 85-90% of its pharma sales.
👍1